Question raised by the PMDA [Design Issues]

posted by Ben – Germany, 2021-03-19 16:47 (1920 d 09:43 ago) – Posting: # 22275
Views: 3,820

Hi Helmut

❝ Based on the agency’s question, what do they require in such a study?


This is what came to my mind.

❝ Problematic in the Japanese population is the (age-dependent) high percentage of achlorohydric subjects. IIRC, already at an age of 20 years it is about 20% and increases to more than 80% at 60 years.


Oh, this is interesting. I was not aware of this phenomenon. Do you have a reference and/or an explanation why this is the case?


Best regards,
Ben.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
142 visitors (0 registered, 142 guests [including 28 identified bots]).
Forum time: 03:30 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5